Project Grant R43HL158304
Award Date
8/6/21
Completion Date
7/31/22
Dollars Obligated
$1.5M
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $500,000 to Starlight Cardiovascular, Inc., a for-profit medical device company based in San Diego, California. The funding will support the company's efforts to finalize the manufacturing processes, produce devices for clinical use, and obtain Investigational Device Exemption (IDE) approval from the FDA to begin a clinical trial for...
This federal Project Grant award for $220,000, provided by the National Science Foundation's (NSF) Division of Mathematical Sciences under the Mathematical and Physical Sciences program (CFDA 47.049), aims to deliver a comprehensive mathematical and computational framework for optimizing the design of next-generation stents. Key products and services to be provided under this 3-year award (August 1, 2024 to July 31, 2027) include: Developing a reduced model optimization module for the optimal...
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, awarded a $719,626 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the Rector & Visitors of the University of Virginia. The grant supports research to develop a novel approach for mitigating intimal hyperplasia, a common complication of vascular surgery, by targeting the enzyme ALDH1A3. The researchers aim to elucidate the role of ALDH1A3 in endothelial cell...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), will support research to optimize surgical procedures for congenital aortic valve disease. The $181,392 award to The Leland Stanford Junior University aims to leverage computational modeling and in vitro testing to guide the design of two promising surgical interventions: bicuspidization repair and bioprinted valve replacement. The...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $437,461 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to 3DT Holdings, LLC, a minority-owned biomedical engineering company in San Diego, California. The grant will fund the development and validation of a novel stabilization catheter for His pacing lead implantation, a critical procedure for treating heart failure patients with left bundle branch block. The project aims to refine the design of a...
The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), awarded a $481,245 Project Grant to the University of Pittsburgh to develop a novel ticagrelor-coated stent. This innovative stent aims to eliminate the need for dual antiplatelet therapy after percutaneous coronary intervention (PCI) procedures, which currently carry a high risk of bleeding complications. Through this grant, the University of Pittsburgh will conduct...
This $148,548 Project Grant award from the National Heart, Lung, and Blood Institute under the Cardiovascular Diseases Research Program (CFDA 93.837) supports the development of a 3D bioprinted heart tube model to investigate the causes of hypoplastic left heart syndrome (HLHS), a severe congenital heart defect. The primary objectives are to utilize this 3D in vitro model to interrogate how dysregulated biomechanical forces and microenvironmental stiffness impede cardiac proliferation, a key...
The National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), awarded a $499,103 project grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Alleviant Medical, Inc. The funding will support the commercial readiness of Alleviant's no-implant interatrial shunt therapy to treat heart failure. The project has two key aims: (1) implement high-volume manufacturing capabilities and establish production readiness for the ALV1...
This $413,595 Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports the development of a novel "Magnetic Rotational Platform for Coronary Lesions". The project aims to create an advanced medical device technology that uses magnetic fields to safely and effectively debulk severely calcified coronary lesions, enabling improved stent delivery and treatment of cardiovascular disease. The...
The federal Project Grant award R41HL176279, funded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports the development of an innovative, single-operator pneumothorax decompression device. The $397,891 grant will be used by Advanced Medical Electronics Corp, a for-profit medical technology company, to design, manufacture, and evaluate a prototype device aimed at improving the safety and time efficiency of therapeutic...